Acinetobacter baumannii infection and drug resistance of.docVIP

 PAGE \* MERGEFORMAT 14 Acinetobacter baumannii infection and drug resistance of [Abstract] Acinetobacter baumannii is an important pathogen of nosocomial infection, infection on the rise in recent years, and its growing drug resistance. In this paper, drug resistance of Acinetobacter baumannii and Selection of antimicrobial agents were reviewed for clinical treatment Acinetobacter baumannii infection to help. [Keywords:] Acinetobacter baumannii; drug resistance; antibacterial drugs Constitute the major pathogens of nosocomial infection and qualifying is not static, but with the hospital environment, medical treatment and technology, changes in the distribution of diseases in patients with change. Over the past that the weak pathogenic bacteria of the genus Acinetobacter, As widely distributed in nature, the human body surface and the hospital environment, ability to survive and often can cause the environment, pollution, goods and medical devices and nosocomial infection. Acinetobacter nosocomial infection in recent years, rapid growth in the isolation rate The bacteria, Acinetobacter baumannii which is most common in clinical practice is an important pathogen of nosocomial infection, especially in multi-resistant Acinetobacter baumannii, nosocomial infection has become an important pathogen outbreak [1], causing the clinical and microbiological scholars of serious concern. Acinetobacter baumannii is the occurrence rate of pulmonary infection caused by bacteria increased rapidly and has become a major nosocomial pathogen lung [2], but also can cause sepsis, urinary tract infection, following onset of meningitis. Acinetobacter baumannii in a hospital environment is widely distributed and long-term survival of critically ill patients, including intensive cardiac care unit (CCU and ICU (ICU patients a big threat, easy to cause an outbreak in the ICU [3,4]. domestic resistance to penicillin thin carbon Acinetobacter baumannii class developed rapidly